Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001004197 | SCV001163033 | pathogenic | Autosomal recessive polycystic kidney disease | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001004197 | SCV002236022 | pathogenic | Autosomal recessive polycystic kidney disease | 2021-09-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 813378). This premature translational stop signal has been observed in individual(s) with clinical features of polycystic kidney disease (PMID: 23582048). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ala2355Leufs*60) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). |
Baylor Genetics | RCV003461306 | SCV004204746 | pathogenic | Polycystic kidney disease 4 | 2022-12-29 | criteria provided, single submitter | clinical testing |